Quality Data Model (QDM) Style Guide. QDM (version MAT) for Meaningful Use Stage 2

Similar documents
Stage 2 Eligible Professional Meaningful Use Core Measures Measure 15 of 17 Last Updated: November 2013

Stage 2 Eligible Hospital and Critical Access Hospital Meaningful Use Core Measures Measure 12 of 16 Date issued: May 2013

HIT Standards Committee Clinical Quality Workgroup and Vocabulary Task Force

Quality Data Model December 2012

Computer Provider Order Entry (CPOE)

May 7, Submitted electronically via:

Copyright All Rights Reserved.

Merit-Based Incentive Payment System (MIPS) Advancing Care Information Performance Category Transition Measure 2018 Performance Period

Medicaid EHR Incentive Program Health Information Exchange Objective Stage 3 Updated: February 2017

May 7, Re: Document ID RIN 0991-AB82. Dear Dr. Mostashari:

MEANINGFUL USE STAGE 2

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 2

Measures Reporting for Eligible Hospitals

Appendix 4 CMS Stage 1 Meaningful Use Requirements Summary Tables 4-1 APPENDIX 4 CMS STAGE 1 MEANINGFUL USE REQUIREMENTS SUMMARY

Qualifying for Medicare Incentive Payments with Crystal Practice Management. Version 1.0

Meaningful Use: Review of Changes to Objectives and Measures in Final Rule

Measures Reporting for Eligible Providers

Sevocity v Advancing Care Information User Reference Guide

APPENDIX 2 NCQA PCMH 2011 AND CMS STAGE 1 MEANINGFUL USE REQUIREMENTS

Appendix 5. PCSP PCMH 2014 Crosswalk

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 1

Vendor Plan Share, Panel Discussion: Clinical Data Exchange by leveraging the EHR

during the EHR reporting period.

Roll Out of the HIT Meaningful Use Standards and Certification Criteria

STAGE 2 PROPOSED REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1

PCSP 2016 PCMH 2014 Crosswalk

CHIME Concordance Analysis of Stage 2 Meaningful Use Final Rule - Objectives & Measures

HIE Implications in Meaningful Use Stage 1 Requirements

emeasures: Everything You Want To Know

A complete step by step guide on how to achieve Meaningful Use Core Set Measures in Medgen EHR.

Meaningful Use Stage 1 Guide for 2013

Section 7: Core clinical headings

SNOMED CT AND ICD-10-BE: TWO OF A KIND?

Carolinas Collaborative Data Dictionary

ecw and NextGen MEETING MU REQUIREMENTS

Meaningful Use Stage 2 Clinical Quality Measures Are You Ready?

Meaningful Use Modified Stage 2 Roadmap Eligible Hospitals

Meaningful Use Measures: Quick Reference Guide Stage 2 (2014 and Beyond)

Calibrating your tablet allows you to ensure accuracy as you handwrite on the screen and/or select items on the screen. Prime Clinical Systems, Inc 1

Medicare and Medicaid EHR Incentive Program. Stage 3 and Modifications to Meaningful Use in 2015 through 2017 Final Rule with Comment

Measure: Patient name. Referring or transitioning healthcare provider's name and office contact information (MIPS eligible clinician only) Procedures

Merit-Based Incentive Payment System (MIPS) Promoting Interoperability Performance Category Measure 2018 Performance Period

Merit-Based Incentive Payment System (MIPS) Promoting Interoperability Performance Category Transition Measure 2018 Performance Period

Re: Voluntary 2015 Edition Electronic Health Record (EHR) Certification Criteria; Interoperability Updates and Regulatory Improvements

Care Management Policies

Eligible Professionals (EP) Meaningful Use Final Objectives and Measures for Stage 1, 2011

Stage 1 Meaningful Use Objectives and Measures

Meaningful use glossary and requirements table

Clinical LOINC Meeting - Salt Lake City, UT USA. Updates on LOINC. Daniel J. Vreeman, PT, DPT, MSc

Patient Electronic Access Modified Stage 2: Objective 8

REQUIREMENTS GUIDE: How to Qualify for EHR Stimulus Funds under ARRA

Medicare and Medicaid Programs: Electronic Health Record Incentive Program -- Stage 3 and Modifications to Meaningful Use in 2015 through 2017

Part 2: PCMH 2014 Standards

Eligible Professional Core Measure Frequently Asked Questions

Harnessing the Power of MHS Information Systems to Achieve Meaningful Use of Health Information

Quanum Electronic Health Record Frequently Asked Questions

1. What are the requirements for Stage 1 of the HITECH Act for CPOE to qualify for incentive payments?

Achieving Meaningful Use with Centricity Electronic Medical Record

9/28/2011. Learning Agenda. Meaningful Use and why it s here. Meaningful Use Rules of Participation. Categories, Objectives and Thresholds

Terminology in Healthcare and

PCMH 2014 Recognition Checklist

ARRA New Opportunities for Community Mental Health

Meaningful Use Certification Details

Medication Reconciliation and Standards Overview

Care360 EHR Frequently Asked Questions

Using Centricity Electronic Medical Record Meaningful Use Reports Version 9.5 January 2013

Version 11.5 Patient-Centered Medical Home (PCMH) 2014 Reference Guide for Sevocity Users

Patient Centered Medical Home 2011

Meaningful Use Modified Stage 2 Roadmap Eligible Professionals

Iatric Systems Supports the Achievement of Meaningful Use

Chapter Three: Direct Care Functions

CHCANYS NYS HCCN ecw Webinar

HIE Implications in Meaningful Use Stage 1 Requirements

Test Procedure for (c) Maintain up-to-date problem list

Site/Facility: Area: 1. Communication & Outreach Person(s) Responsible Date Due Complete Comments 1.1. EHR/MU team meetings on a routine basis

THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE. Angel L. Moore, MAEd, RHIA Eastern AHEC REC

Practice Tools for Safe Drug Therapy

Go! Knowledge Activity: Meaningful Use and the Hospital EHR

Section 6: Referral record headings

Via Electronic Submission to:

Webinar #5 Meaningful Use: Looking Ahead to Stage 2 and CPS 12

3. ASSESSING THE FEASIBILITY OF MEASURING QUALITY WITH CLAIMS DATA

Meaningful Use Roadmap

Measure #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

Falcon Quality Payment Program Checklist- 2017

Measure #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

Note: Every encounter type must have at least one value designated under the MU Details frame.

Promoting Interoperability Measures

EHR Meaningful Use Guide

Quality ID #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

Understanding Your Meaningful Use Report

Practice Transformation: Patient Centered Medical Home Overview

Completeness, Timeliness, and Validity

5.8 Overview of Enhancements

Merit-Based Incentive Payment System (MIPS) Promoting Interoperability Performance Category Measure 2018 Performance Period

Meaningful Use Stage 2. Physician Office October, 2012

Merit-Based Incentive Payment System (MIPS) Advancing Care Information Performance Category Measure

Stage 2 Eligible Professional Meaningful Use Core and Menu Measures. User Manual/Guide for Attestation using encompass 3.0

2015 HCPro, a division of BLR. All rights reserved. These materials may not be duplicated without express written permission.

Transcription:

Quality Data Model (QDM) Style Guide QDM (version MAT) for Meaningful Use Stage 2

Introduction to the QDM Style Guide The QDM Style Guide provides guidance as to which QDM categories, datatypes, and attributes can be found in a structured form in electronic health records (EHRs) and which may require additional effort for structured representation within EHRs. This effort includes adjustment of the electronic user interface for structured data capture, interface from non EHR systems, natural language processing or other means to translate point of care data into emeasures 1 while preserving semantic meaning. The Style Guide is based on Meaningful Use Stage 2 quality measures and EHRs certified for the 2014 EHR Certification Program, by the Office of the National Coordinator for Health IT (ONC). Intended Use The QDM Style Guide is intended to help identify datatypes and attributes readily found in 2014 certified EHRs when creating emeasures. Structure of Style Guide The QDM Style Guide is presented in a table format. For each QDM Category, the related standards recommended by the Federal Advisory Act (FACA) Health IT s Committee and those incorporated in the Final 2014 Edition EHR Certification Criteria 2 are provided. The Guide also provides guidance as to what might be expected as structured data available in EHRs that adhere to the final 2014 certification criteria and what data criteria may require additional effort within EHRs. 1 The emeasure is the electronic format for quality measures using the QDM and the Healthcare Quality Measure Format (HQMF), an HL7standard. 2 Available at: http://www.gpo.gov/fdsys/pkg/fr-2012-03-07/pdf/2012-4430.pdf. National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 1

Column Header Definitions: 1. QDM Category refers to a particular group of information that can be addressed in a quality measure. s list the Vocabulary (Code system) recommendations provided by the HITSC with modifications as included in the Final 2014 Edition EHR Certification Criteria and ONC 2014 EHR Certification (final) section that discusses the information category. 2. Feasible includes those datatypes (context of use) and attributes that should be present in structured form in an EHR meeting final 2014 certification requirements. 3. Feasible but require additional effort, e.g., workflow changes lists datatype (or contexts of use) and attributes that cannot be expected to be present in an EHR meeting final 2014 certification requirements. Some EHRs may be able to provide the level of detail required by these Datatype or attributes. Many will require a change to clinician workflow to document in structured format data currently captured external to the EHR or in unstructured text, or to document information that is not part of a standard workflow. Such data may be available by postdocumentation methods such as natural language processing and/or abstraction of some data components. To limit the potential extra burden on the part of clinicians, such elements should not be used in measures designed for data captured exclusively by EHRs without testing to be certain of data availability. In summary, this second column of feasibility issues require one of the following: a. entry by clinicians of structured data where current practice addresses unstructured data, OR b. entry by the clinician that is not currently documented, or request of the clinician to evaluate the output of other post-documentation methods such as natural language processing and/or abstraction of some data components. National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 2

QDM Feasible but require additional effort for capture Category s Feasible* through the EHR (workflow changes)** This version of the QDM Substance, Adverse Event does not have Substance, Allergy a specific Substance, Intolerance allergy/ adverse event category SNOMED-CT to describe the allergic reaction RxNorm for Medications that are the causative agents SNOMED-CT for non-medication substances that are causative agents 170.314(a)(2) Drug-drug, drug-allergy interaction checks 170.314(a)(7) Medication allergy list Device, Adverse Event Device, Allergy Diagnostic Study, Adverse Event Diagnostic Study, Intolerance Intervention, Adverse Event Intervention, Intolerance Laboratory Test, Adverse Event Laboratory Test, Intolerance Medication, Adverse Event Medication, Allergy Medication, Intolerance Procedure, Adverse Event Procedure, Intolerance Reaction Provider preference National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 3

Care Goal Dependent on the type of information expressed as the goal. E.g.: a) Improvement in Body Mass Index (BMI) uses the vocabulary for the physical exam element (LOINC) and numerical or SNOMED-CT for the result b) Patient understanding of education provided uses SNOMED-CT 170.205(a)(3) Consolidated CDA Care Goal Related to Provider preference National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 4

Individual Characteristic Varies by characteristic: ISO 639-2 constrained to elements in ISO 639-1 for Patient s Preferred Language (Mapping maintained by Library of Congress: http://www.loc.gov/standards/iso639-2/php/code_list.php) CDC PHIN-VADS HL7 for Administrative Gender CDC PHIN-VADS HL7 Race and Ethnicity (use broadest range of code sets within CDC listed for Race, Ethnicity, or both combined) Identical to OMB Race and Ethnicity values LOINC-For assessment instruments, (including tobacco use) SNOMED-CT-Appropriate Responses to Instruments (including patient preferences and behaviors) Payer Typology of the Public Health Data s Consortium for characterizing payers 170.314(a)(3) Demographics 170.207(j) ISO 639-1:2002 (preferred language) No standard specified Patient Sex 170.207(f) OMB standards for the classification of federal data on race and ethnicity 170.207(l) smoking status types 170.314(a)(11) smoking status No standard specified s and behaviors No standard specified Payer Patient characteristic Patient characteristic birth date Patient characteristic expired Patient characteristic clinical trial participant Patient characteristic payer Patient characteristic sex Patient characteristic ethnicity Patient characteristic race Time (for expired) Date (for expired) Provider characteristic Reason National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 5

Communication SNOMED-CT 170.314(d)(1) Authentication, access control, and authorization s 170.314(a)(15) Ambulatory setting only patient reminders 170.314(b)(1) Transitions of care receive, display, and incorporate transition of care/ referral summaries (level 2 effort) 170.314(b)(2) Transitions of care -Create and transmit transition of care/ referral summaries (level 3 effort) 170.205(a)(3) Consolidated CDA 170.202(a)(1) Applicability Statement for Secure Health Transport 170.202(a)(2) XDR and XDM for Direct Messaging 170.202(a)(3) SOAP Based Secure Transport RTM version 1.0 Communication: From Patient to Provider Communication: From Provider to Patient Provider preference Condition/ Diagnosis/ Problem SNOMED-CT 170.314(a)(5) Problem List 170.314(a)(13) Family health history 170.207(m) Encounter diagnoses [ICD-10 (ICD- 10-CM and ICD-10-PCS, respectively)] Diagnosis, Active Diagnosis, Family History Diagnosis, Inactive Diagnosis, Resolved laterality ordinality severity start datetime status stop datetime negation rationale patient preference provider preference National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 6

Device Diagnostic Study (nonlaboratory) SNOMED-CT 170.210(e) Record actions related to electronic health information, audit log status, and encryption of end user devices for purposes of reporting safety events No standard directly related to device use LOINC study name SNOMED-CT appropriate findings UCUM specific units of measure 170.314(a)(12) Imaging [Level 2 Effort] Device, Adverse Event Device, Allergy Device, Applied Device, Intolerance Device, Order Anatomical structure Removal datetime Reason reaction start datetime stop datetime Diagnostic Study, Adverse Event Diagnostic Study, Intolerance Diagnostic Study, Order Diagnostic Study, Performed Diagnostic Study, Result method reason result status start datetime stop datetime Device, Recommended negation rationale patient preference provider preference Diagnostic Study, Recommended negation rationale patient preference provider preference radiation dosage radiation duration National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 7

Intervention LOINC for interactions that produce an assessment or measurable results SNOMED-CT for appropriate results and interventions that do not produce measurable results (e.g., counseling) 170.314(a)(15) Patient-specific education resources [At a minimum, each one of the data elements included in the patient's: problem list; medication list; and laboratory tests and values/results; and the standard specified at 170.204(b)(1)] Intervention, Adverse Event Intervention, Intolerance Intervention, Order Intervention, Performed Intervention, Result method reason result reaction start datetime stop datetime Intervention, Recommended negation rationale patient preference provider preference Encounter SNOMED-CT No specific standard to identify an encounter. s are identified for Encounter diagnoses (See Condition / Diagnosis / Problem section) Encounter, Active Encounter, Performed Encounter, Order admission datetime discharge datetime facility location arrival datetime facility location departure datetime length of stay Discharge status Facility location Encounter, Recommended Reason Provider Preference Frequency (for Home Care Use) National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 8

Care Experience LOINC for assessment instruments SNOMED-CT for appropriate responses No specific standard to identify experience Functional Status ICF (International Classification of Functioning, Disability and Health) for categories of function LOINC for assessment instruments SNOMED-CT for appropriate responses No specific standard to identify functional status Functional Status, Performed (Note: Limited to Calculated Form and use of validated instruments registered in LOINC) Functional Status, Result Functional Status, Order Result method reason start datetime stop datetime Provider Care Experience Patient Care Experience negation rationale patient preference provider preference start datetime stop datetime Functional Status, Performed (Note: for functional status performed other than Calculated Forms and use of validated instruments registered in LOINC) Functional Status, Recommended negation rationale patient preference provider preference National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 9

Laboratory Test LOINC for the test name and its results SNOMED-CT for applicable result values UCUM for units of measure 170.314(b)(5) Incorporate laboratory tests and values/results 170.314(f)(4) Transmission of reportable laboratory tests and values/ results Laboratory Test, Adverse Event Laboratory Test, Intolerance Laboratory Test, Order Laboratory Test, Performed Laboratory Test, Result Method Status reaction reason Result Laboratory Test, Recommended Provider preference Laterality Facility location Cardinality (1,2,3...) Alerted National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 10

Medication RxNorm for medications CVX for vaccinations (acknowledging that vaccinations are treated as medications in some contexts and as a separate category in others) 170.299 by reference includes medications 170.207(h) Medications for transitions of care and ambulatory clinical summaries 170.314(a)(6) Medication list 170.314(a)(16) Electronic medication administration record 170.314(b)(3) Electronic prescribing 170.314(b)(4) Clinical record reconciliation (covers Medication List, Allergy List and Problem List) Medication, Active Medication, Administered Medication, Adverse Event Medication, Allergy Medication, Dispensed Medication, Discharge Medication, Intolerance Medication, Order Cumulative medication duration Date Dose Frequency Method Number Reason Reaction Refills Route Time Infusion duration Provider preference National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 11

Physical Exam LOINC for assessment instruments and individual examination elements SNOMED-CT for appropriate responses 170.314(a)(4) Vital signs, body mass index, and growth charts Physical Exam, Performed Result (limited to vital signs that are captured as structured data and also data that are captured in routine inpatient assessments) Physical Exam, Finding (In addition to vital signs that are captured as structured data) Physical Exam, Order Physical Exam, Recommended Anatomical structure Facility location Provider preference Reason Procedure SNOMED-CT 170.207(b)(2) HCPCS and CPT-4 OR 170.207(b)(3) ICD-10 PCS Procedure, Adverse Event Procedure, Intolerance Procedure, Order Procedure, Performed Procedure, Result Incision datetime Reason Reaction Result Procedure, Recommended Method Ordinality negation rationale patient preference provider preference radiation dosage radiation duration Status National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 12

Risk Category/ Assessment LOINC for assessment instruments SNOMED-CT for appropriate responses No specific standard to identify risk category/ assessment Risk category assessment (Note: Requires Calculated Form Capability and use of validated instruments registered in LOINC) negation rationale patient preference provider preference Substance SNOMED-CT Non-medication substances are not referenced start datetime stop datetime result Result Date time Substance, Administered Substance, Adverse Event Substance, Allergy Substance, Intolerance Substance, Order Substance, Recommended Attributes Dose Frequency Attributes Date Reaction Refills Route Time Method Number Provider Preference Reason National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 13

Symptom SNOMED-CT Symptoms are not referenced Symptom, Active Symptom, Assessed Symptom, Inactive Symptom, Resolved Environment Provider preference Ordinality (principal, secondary,...) Severity Status System Characteristic LOINC for healthcare resources (staffing) HL7 for EHR functions SNOMED-CT for equipment System characteristics are not referenced System characteristic National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 14

Transfer of care SNOMED-CT 170.205(a)(3) references information requirements for transitions of care but the process of transition is not referenced 170.314(b)(1) Transitions of care receive, display, and incorporate transition of care/ referral summaries (level 2 effort) 170.314(b)(2) Transitions of care -Create and transmit transition of care/ referral summaries (level 3 effort) Transfer from Transfer to Provider preference * Data that should be present in structured form in a Meaningful Use 2014 Certified HER ** Feasible but require additional effort, such as the following workflow changes: a. entry by clinicians of structured data where current practice addresses unstructured data, OR b. entry by the clinician that is not currently documented, or request of the clinician to evaluate the output of other post-documentation methods such as natural language processing and/or abstraction of some data components. National Quality Forum QDM (version MAT) Meaningful Use Stage 2 October 2012 15